Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,479
Award facts
- Contract value 100% obligated
- $38,478.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order valued at $38,478.60 from the Defense Logistics Agency on November 13, 2025, with an ultimate completion date of November 24, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating the award was made through open competition. The delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded the same day with a $499.9 billion ceiling value through December 31, 2036.
The PPV-G GEN V program represents a comprehensive $30.3 billion acquisition strategy designed to supply the Department of Defense's global medical logistics needs. Under this contract vehicle, DMS Pharmaceutical Group is authorized to deliver a broad range of pharmaceuticals and medical consumables—including branded and generic prescription medications, biologics, vaccines, oncology treatments, and specialty surgical products—to military healthcare facilities worldwide. The company's demonstrated capacity to manage diverse and specialized pharmaceutical requirements positions it as a critical regional supplier within the federal military medical supply chain, with delivery orders structured to support recurring operational needs across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DU26FEMMW?
SPE2DU26FEMMW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DU26FEMMW worth?
The government has obligated $38,479 on SPE2DU26FEMMW.
Is contract SPE2DU26FEMMW an order under another contract?
Yes. SPE2DU26FEMMW is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMW competed?
The extent of competition for SPE2DU26FEMMW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award